These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 826241)

  • 1. Effects of zinc sulfate on Pseudomonas aeruginosa infections and protease in rabbit corneas.
    Mondino BJ; Kessler E; Gipson LL; Brown SI
    Arch Ophthalmol; 1976 Dec; 94(12):2149-52. PubMed ID: 826241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagenase inhibitors in Pseudomonas keratitis. Adjuncts to antibiotic therapy in rabbits.
    Bohigian G; Valenton M; Okumoto M; Caraway BL
    Arch Ophthalmol; 1974 Jan; 91(1):52-6. PubMed ID: 4357789
    [No Abstract]   [Full Text] [Related]  

  • 3. Chelation in experimental Pseudomonas keratitis.
    Wilson LA
    Br J Ophthalmol; 1970 Sep; 54(9):587-93. PubMed ID: 4318751
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.
    Burns FR; Paterson CA; Gray RD; Wells JT
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2065-9. PubMed ID: 2127341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS; Hobden JA; Jantzen JA; Gonzalez JR; O'Callaghan RJ; Hill JM
    Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
    Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
    J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P; Riske PS; Zaya NE; Carey R; Bouchard CS
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas.
    Hobden JA; Rootman DS; O'Callaghan RJ; Hill JM
    Antimicrob Agents Chemother; 1988 Jul; 32(7):978-81. PubMed ID: 3142344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of two ciprofloxacin formulations for experimental Pseudomonas and Staphylococcus keratitis.
    Engel LS; Callegan MC; Hill JM; Folkens AT; Shimomura Y; O'Callaghan RJ
    Jpn J Ophthalmol; 1996; 40(2):212-9. PubMed ID: 8876389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model.
    Sensoy D; Cevher E; Sarici A; Yilmaz M; Ozdamar A; Bergişadi N
    Eur J Pharm Biopharm; 2009 Aug; 72(3):487-95. PubMed ID: 19223014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
    Hobden JA; Reidy JJ; O'Callaghan RJ; Hill JM; Insler MS; Rootman DS
    Arch Ophthalmol; 1988 Nov; 106(11):1605-7. PubMed ID: 3142450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP; Sawusch MR; Dick JD; Gottsch JD
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ; Friedlaender MH; Lee A; Okumoto M
    Cornea; 1989 Sep; 8(3):188-90. PubMed ID: 2501067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa proteases and corneal virulence.
    Hobden JA
    DNA Cell Biol; 2002; 21(5-6):391-6. PubMed ID: 12167241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antimicrobial peptides in ophthalmology: an experimental study in corneal preservation and the management of bacterial keratitis.
    Mannis MJ
    Trans Am Ophthalmol Soc; 2002; 100():243-71. PubMed ID: 12545697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between proteases and descemetocele formation in experimental Pseudomonas keratitis.
    Twining SS; Davis SD; Hyndiuk RA
    Curr Eye Res; 1986 Jul; 5(7):503-10. PubMed ID: 3527568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
    Thibodeaux BA; Caballero AR; Dajcs JJ; Marquart ME; Engel LS; O'Callaghan RJ
    Ocul Immunol Inflamm; 2005; 13(2-3):169-82. PubMed ID: 16019676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.
    Kupferman A; Leibowitz HM
    Arch Ophthalmol; 1979 Sep; 97(9):1699-1702. PubMed ID: 224848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.